Constellation Pharmaceuticals

$23.74
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$1.85 (+8.45%) As of 4:26 PM UTC today

Why Robinhood?

You can buy or sell CNST and other stocks, options, and ETFs commission-free!

About CNST

Constellation Pharmaceuticals, Inc. Common Stock, also called Constellation Pharmaceuticals, is a clinical-stage biopharmaceutical company, which engages in the development of novel therapeutics in the field of epigenetics.

CEO
Jigar Raythatha
Employees
154
Headquarters
Cambridge, Massachusetts
Founded
2008
Market Cap
1.19B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
471.12K
High Today
$23.88
Low Today
$22.03
Open Price
$22.03
Volume
490.59K
52 Week High
$50.90
52 Week Low
$17.00

CNST Earnings

-$0.82
-$0.55
-$0.27
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 5, Pre-Market

You May Also Like

BOB
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure